Eversana
Eversana, officially known as Eversana Life Science Services, is a leading provider of commercial services for the life sciences industry, headquartered in the United States. Founded in 2018, the company has rapidly established itself as a key player in the healthcare sector, offering a comprehensive suite of solutions that span market access, patient support, and commercialisation strategies. With a strong presence across North America and Europe, Eversana is dedicated to enhancing patient outcomes through innovative services tailored to the unique needs of biopharmaceutical companies. Their core offerings, including integrated market access and patient engagement solutions, set them apart by ensuring that therapies reach the patients who need them most. Eversana's commitment to excellence has earned it a notable position in the market, recognised for its ability to drive efficiency and improve patient experiences in an increasingly complex healthcare landscape.
DitchCarbon Score
How does Eversana's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eversana's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eversana's reported carbon emissions
Eversana, headquartered in the United States, currently does not have publicly available carbon emissions data for the most recent year. However, the company has made significant commitments towards reducing its carbon footprint. Eversana is actively engaged in setting near-term reduction targets, with a status of "Committed" as of early 2024. While specific numerical targets have not been disclosed, the company is focused on addressing its emissions within the pharmaceuticals, biotechnology, and life sciences sector. Eversana has not yet committed to a net-zero target, indicating that while they are taking steps towards sustainability, they have not established a long-term goal for complete carbon neutrality. The company is working within the framework of the Science Based Targets initiative (SBTi), which underscores its commitment to aligning its emissions reduction strategies with climate science. In summary, while Eversana has not released specific emissions data or reduction targets, it is committed to improving its environmental impact through strategic initiatives in the pharmaceutical and life sciences industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eversana is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
